Acutus Medical (NASDAQ:AFIB – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, earnings, profitability, valuation, risk, institutional ownership and dividends.
Profitability
This table compares Acutus Medical and KORU Medical Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Acutus Medical | -272.74% | -311.64% | -11.57% |
| KORU Medical Systems | -5.27% | -13.61% | -8.33% |
Earnings and Valuation
This table compares Acutus Medical and KORU Medical Systems”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Acutus Medical | $7.16 million | 0.00 | -$81.66 million | ($0.11) | N/A |
| KORU Medical Systems | $43.26 million | 4.36 | -$2.64 million | ($0.05) | -82.20 |
KORU Medical Systems has higher revenue and earnings than Acutus Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Acutus Medical has a beta of 5.67, meaning that its share price is 467% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.41, meaning that its share price is 59% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and target prices for Acutus Medical and KORU Medical Systems, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Acutus Medical | 0 | 0 | 0 | 0 | 0.00 |
| KORU Medical Systems | 1 | 0 | 4 | 0 | 2.60 |
KORU Medical Systems has a consensus price target of $7.25, indicating a potential upside of 76.40%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Acutus Medical.
Insider and Institutional Ownership
56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
KORU Medical Systems beats Acutus Medical on 11 of the 13 factors compared between the two stocks.
About Acutus Medical
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.
